| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pollen | 14 | 2017 | 46 | 3.000 |
Why?
|
| Asthma | 15 | 2022 | 756 | 2.790 |
Why?
|
| Allergens | 13 | 2018 | 252 | 2.280 |
Why?
|
| Neutrophils | 7 | 2017 | 381 | 1.870 |
Why?
|
| DNA Damage | 10 | 2022 | 513 | 1.760 |
Why?
|
| Immunity, Innate | 7 | 2018 | 372 | 1.650 |
Why?
|
| Neutrophil Infiltration | 5 | 2017 | 64 | 1.610 |
Why?
|
| DNA Glycosylases | 13 | 2023 | 32 | 1.560 |
Why?
|
| Antigens, Plant | 7 | 2017 | 33 | 1.470 |
Why?
|
| Respiratory Hypersensitivity | 6 | 2016 | 52 | 1.450 |
Why?
|
| Lung | 14 | 2021 | 1496 | 1.360 |
Why?
|
| Oxidative Stress | 16 | 2022 | 837 | 1.240 |
Why?
|
| DNA Repair | 10 | 2022 | 585 | 1.240 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2017 | 24 | 1.120 |
Why?
|
| Th2 Cells | 6 | 2017 | 185 | 1.110 |
Why?
|
| Respiratory Mucosa | 8 | 2018 | 91 | 1.100 |
Why?
|
| Dander | 3 | 2018 | 6 | 1.100 |
Why?
|
| Hypersensitivity | 5 | 2018 | 185 | 1.030 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2018 | 15 | 1.000 |
Why?
|
| Reactive Oxygen Species | 16 | 2022 | 499 | 0.960 |
Why?
|
| Bronchoalveolar Lavage Fluid | 9 | 2017 | 149 | 0.900 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2017 | 139 | 0.880 |
Why?
|
| Plant Extracts | 6 | 2017 | 121 | 0.850 |
Why?
|
| Ambrosia | 8 | 2017 | 14 | 0.810 |
Why?
|
| NF-kappa B | 5 | 2021 | 459 | 0.790 |
Why?
|
| Guanine | 9 | 2022 | 61 | 0.720 |
Why?
|
| Pneumonia | 5 | 2018 | 325 | 0.710 |
Why?
|
| Interleukin-8 | 3 | 2017 | 209 | 0.690 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2016 | 5 | 0.630 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2018 | 9 | 0.620 |
Why?
|
| Cytosine | 1 | 2018 | 56 | 0.610 |
Why?
|
| Inflammation | 11 | 2022 | 1446 | 0.600 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 188 | 0.590 |
Why?
|
| Cytokines | 8 | 2017 | 1288 | 0.590 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 49 | 0.590 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 9 | 0.590 |
Why?
|
| Cats | 5 | 2018 | 119 | 0.580 |
Why?
|
| Animals | 41 | 2023 | 34232 | 0.560 |
Why?
|
| Blood-Air Barrier | 1 | 2017 | 4 | 0.550 |
Why?
|
| Mice, Knockout | 12 | 2018 | 3744 | 0.540 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.530 |
Why?
|
| Alternaria | 2 | 2015 | 4 | 0.510 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 145 | 0.500 |
Why?
|
| Interleukin-18 | 2 | 2015 | 61 | 0.490 |
Why?
|
| NADH, NADPH Oxidoreductases | 2 | 2015 | 12 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.460 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 171 | 0.460 |
Why?
|
| DNA | 7 | 2022 | 1608 | 0.450 |
Why?
|
| Mice | 30 | 2022 | 17631 | 0.430 |
Why?
|
| Respiratory System | 3 | 2014 | 97 | 0.420 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 678 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 15 | 2017 | 997 | 0.410 |
Why?
|
| Pandemics | 1 | 2020 | 1107 | 0.400 |
Why?
|
| GTP Phosphohydrolases | 2 | 2014 | 147 | 0.340 |
Why?
|
| Th1 Cells | 1 | 2009 | 153 | 0.310 |
Why?
|
| Airway Remodeling | 3 | 2018 | 21 | 0.310 |
Why?
|
| Epithelial Cells | 2 | 2014 | 909 | 0.300 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1711 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 4404 | 0.290 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2009 | 135 | 0.280 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4395 | 0.280 |
Why?
|
| Interferon-gamma | 1 | 2009 | 505 | 0.280 |
Why?
|
| Nitrate Reductase (NAD(P)H) | 1 | 2007 | 1 | 0.280 |
Why?
|
| Bronchitis | 1 | 2007 | 34 | 0.270 |
Why?
|
| NADPH Oxidases | 2 | 2013 | 114 | 0.260 |
Why?
|
| Cell Differentiation | 2 | 2012 | 1898 | 0.240 |
Why?
|
| Nasal Mucosa | 2 | 2017 | 66 | 0.240 |
Why?
|
| Antioxidants | 1 | 2007 | 369 | 0.220 |
Why?
|
| Humans | 29 | 2023 | 125189 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 207 | 0.210 |
Why?
|
| Glutathione Disulfide | 2 | 2017 | 21 | 0.200 |
Why?
|
| Cells, Cultured | 9 | 2015 | 3056 | 0.200 |
Why?
|
| Eosinophils | 2 | 2015 | 118 | 0.190 |
Why?
|
| Ovalbumin | 2 | 2014 | 319 | 0.190 |
Why?
|
| Mucins | 2 | 2015 | 75 | 0.190 |
Why?
|
| Aldehyde Reductase | 2 | 2013 | 17 | 0.190 |
Why?
|
| Biomarkers | 5 | 2018 | 3091 | 0.190 |
Why?
|
| CpG Islands | 1 | 2002 | 323 | 0.180 |
Why?
|
| Mast Cells | 2 | 2013 | 78 | 0.180 |
Why?
|
| Allergists | 1 | 2020 | 7 | 0.180 |
Why?
|
| Cell Line | 6 | 2015 | 2756 | 0.180 |
Why?
|
| Immunoglobulin E | 3 | 2018 | 160 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 382 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2020 | 23 | 0.170 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 307 | 0.170 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 42 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 55 | 0.170 |
Why?
|
| Masks | 1 | 2020 | 38 | 0.170 |
Why?
|
| Receptors, Virus | 1 | 2020 | 107 | 0.170 |
Why?
|
| Alanine | 1 | 2020 | 187 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 141 | 0.160 |
Why?
|
| Interleukin-5 | 2 | 2018 | 43 | 0.160 |
Why?
|
| Signal Transduction | 7 | 2021 | 4534 | 0.160 |
Why?
|
| Chromatography, Gas | 1 | 2018 | 31 | 0.160 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 9 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2522 | 0.150 |
Why?
|
| Insect Bites and Stings | 1 | 2018 | 38 | 0.140 |
Why?
|
| Genome | 2 | 2023 | 470 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 85 | 0.140 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2017 | 8 | 0.140 |
Why?
|
| Rhinitis, Allergic | 1 | 2017 | 13 | 0.140 |
Why?
|
| Deoxyguanosine | 1 | 2017 | 13 | 0.140 |
Why?
|
| Receptor, PAR-2 | 1 | 2017 | 3 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 122 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 233 | 0.130 |
Why?
|
| Interleukin-12 | 2 | 2009 | 116 | 0.130 |
Why?
|
| Neutrophil Activation | 1 | 2016 | 15 | 0.130 |
Why?
|
| Lactoferrin | 2 | 2007 | 78 | 0.130 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 27 | 0.120 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 244 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1099 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 119 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2020 | 753 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2017 | 733 | 0.120 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mitochondria | 2 | 2009 | 680 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 292 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 656 | 0.110 |
Why?
|
| Antigens | 1 | 2014 | 156 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2820 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2009 | 867 | 0.110 |
Why?
|
| Age Factors | 1 | 2020 | 2823 | 0.110 |
Why?
|
| Prevalence | 1 | 2020 | 2458 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 158 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2015 | 443 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 68 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2015 | 781 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 293 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2014 | 185 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 66 | 0.100 |
Why?
|
| Female | 15 | 2017 | 66806 | 0.100 |
Why?
|
| Cell Movement | 2 | 2021 | 847 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 113 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 2014 | 165 | 0.100 |
Why?
|
| Peroxides | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 89 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2913 | 0.100 |
Why?
|
| Autophagy | 1 | 2015 | 392 | 0.100 |
Why?
|
| Oxidants | 1 | 2011 | 31 | 0.090 |
Why?
|
| Actins | 1 | 2014 | 346 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 208 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 137 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 837 | 0.090 |
Why?
|
| Interleukin-4 | 2 | 2009 | 140 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 314 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2009 | 8 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 23 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1699 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 3 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2009 | 104 | 0.080 |
Why?
|
| Plant Proteins | 2 | 2007 | 76 | 0.080 |
Why?
|
| Histamine Release | 1 | 2009 | 10 | 0.080 |
Why?
|
| Chemokines | 1 | 2009 | 133 | 0.080 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Tretinoin | 1 | 2009 | 118 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2593 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 6338 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 954 | 0.070 |
Why?
|
| Interleukins | 1 | 2009 | 120 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3299 | 0.070 |
Why?
|
| Serotonin | 1 | 2009 | 219 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2012 | 888 | 0.070 |
Why?
|
| Tocopherols | 1 | 2007 | 8 | 0.070 |
Why?
|
| Amaranthus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 78 | 0.070 |
Why?
|
| Oxygenases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Interleukin-13 | 1 | 2007 | 97 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2007 | 62 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2007 | 72 | 0.070 |
Why?
|
| Superoxides | 1 | 2007 | 152 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 180 | 0.070 |
Why?
|
| Adult | 3 | 2017 | 29628 | 0.060 |
Why?
|
| Male | 3 | 2017 | 61525 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 663 | 0.060 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 16 | 0.060 |
Why?
|
| Aldehydes | 1 | 2005 | 31 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 286 | 0.060 |
Why?
|
| Epithelium | 1 | 2005 | 364 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2012 | 1631 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2005 | 569 | 0.060 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2023 | 12 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2015 | 627 | 0.050 |
Why?
|
| Cricetinae | 1 | 2023 | 422 | 0.050 |
Why?
|
| Bronchi | 3 | 2009 | 99 | 0.050 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2002 | 14 | 0.050 |
Why?
|
| Obesity | 1 | 2014 | 2248 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2002 | 49 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 502 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 130 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 165 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2002 | 81 | 0.050 |
Why?
|
| Imidazoles | 1 | 2002 | 203 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 9053 | 0.050 |
Why?
|
| Pyridines | 1 | 2002 | 230 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 581 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 777 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 772 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 287 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 699 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 651 | 0.040 |
Why?
|
| Horses | 1 | 2018 | 90 | 0.040 |
Why?
|
| Insecta | 1 | 2018 | 58 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 42 | 0.040 |
Why?
|
| Middle Aged | 1 | 2017 | 26927 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 168 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 216 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 647 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1033 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2009 | 797 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 46 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 3348 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 43 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 100 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 124 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 132 | 0.030 |
Why?
|
| Airway Resistance | 1 | 2014 | 36 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2014 | 4 | 0.030 |
Why?
|
| Body Fluids | 1 | 2014 | 47 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 149 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 68 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 229 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 187 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 214 | 0.030 |
Why?
|
| Immunity | 1 | 2015 | 192 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 173 | 0.030 |
Why?
|
| Imidazolidines | 1 | 2013 | 4 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 296 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2015 | 150 | 0.030 |
Why?
|
| Tryptases | 1 | 2013 | 20 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 345 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2013 | 29 | 0.030 |
Why?
|
| Vaccination | 1 | 2018 | 963 | 0.030 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 20 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 335 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 486 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2012 | 13 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2012 | 51 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2011 | 35 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 53 | 0.020 |
Why?
|
| Oxazines | 1 | 2011 | 25 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 71 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 703 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 185 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 443 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 384 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 806 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 196 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1197 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 880 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 10 | 0.020 |
Why?
|
| Benzophenanthridines | 1 | 2009 | 2 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 10 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1460 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 22 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 270 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 78 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 63 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 636 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 264 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 149 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1181 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2565 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 344 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 556 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 701 | 0.020 |
Why?
|
| Particle Size | 1 | 2006 | 124 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1290 | 0.020 |
Why?
|
| NADP | 1 | 2005 | 53 | 0.020 |
Why?
|
| NAD | 1 | 2005 | 45 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1697 | 0.020 |
Why?
|
| Proteomics | 1 | 2009 | 502 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1272 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1693 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1020 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4262 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 1102 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 83 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2714 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3892 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 590 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2002 | 511 | 0.010 |
Why?
|